In 2013, the Dr. Paul Janssen Award for Biomedical Research went to Professor David Julius from the University of California in San Francisco. Dr. Julius discovered the molecular mechanism behind thermosensation – the sensory perception of temperature – and the role this mechanism plays in the perception of acute and inflammatory pain. 


In 2013 Janssen Research & Development and the Dr. Guislaan Museum in Ghent announced the winner of the second Dr. Guislain Breaking the Chains of Stigma Award. The Nepalese Matrika Devkota, founder of the organization Koshish, was awarded a prize amounting to 50,000 dollars. Koshish helps people who suffer from psychological disorders. The awarding of this distinction celebrates the pioneering work of persons or organizations that help to diminish the stigma associated with mental health issues and mental illness.

The Dr. Paul Janssen Award for Biomedical Research honors the work of a scientist who has made a major, transformational contribution to the improvement of human health. The prize is also a tribute to Dr. Paul Janssen, the founder of Janssen Pharmaceutica, who died in November of 2003.


Janssen believes that strong corporate results, correct policies and focused activities pave the way towards economic sustainability. 

Janssen must constantly reinvent itself in order to cope with the structural and economic changes that affect its environment. This is why Janssen is committed to build partnerships within an open innovation model, and to the continuous alignment of its cost-competitiveness by only developing medicines with a high therapeutic added value. 

For Janssen this means specifically: being focused and a leader in research & development, and being efficient and progressive in terms of production with the aim of bringing new therapeutic solutions to patients quicker and at less expense, and implementing a growth strategy to ensure our continued investment in all these areas.